Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study

Neuroscience Letters

Volumn 289, Issue 2, 2000, Pages 147-151

  Block, Wolfgang ^a   Bayer, Thomas A ^a   Tepest, Ralf ^a   Träber, Frank ^a   Rietschel, Marcella ^a   Müller, Daniel J ^a   Schulze, Thomas G ^a   Honer, William G ^b   Maier, Wolfgang ^a   Schild, Hans H ^a   Falkai, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Basal ganglia; Frontal lobe; Magnetic resonance spectroscopy; Neurochemistry; Schizophrenia

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

AGE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; FAMILIAL DISEASE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENTAL DISEASE; NERVE DEGENERATION; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ASPARTIC ACID; BASAL GANGLIA; CHOLINE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROTONS; SCHIZOPHRENIA;

EID: 0033921114     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01264-7     Document Type: Article

References (21)

1. American Psychiatric Association, Diagnostic and statistical manual of mental disorders. DSM-IV, 4th edn., Washington D.C., 1994.
2. Bayer T.A., Buslei R., Havas L., Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 271:1999;126-128.
3. Bertolino A., Weinberger D.R. Proton magnetic resonance spectroscopy in schizophrenia. Eur. J. Radiol. 30:1999;132-141.
4. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry. 43:1998;641-648.
5. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psyschiatry. 153:1996;1554-1563.
6. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 508:1987;333-348.
7. Brooks W.M., Hodde-Vargas J., Vargas L.A., Yeo R.A., Ford C.C., Hendren R.L. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol. Psychiatry. 43:1998;263-269.
8. Buchsbaum M.S., Wu J.C., DeLisi L.E., Holcomb H.H., Hazlett E., Cooper-Langston K., Kessler R. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol. Psychiatry. 22:1987;479-494.
9. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry. 36:1994;792-800.
10. Cecil K.M., Lenkinski R.E., Gur R.E., Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 20:1999;131-140.
11. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad. Radiol. 1:1994;211-216.
12. Deicken R.F., Zhou L., Corwin F., Vinogradov S., Weiner M.W. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am. J. Psychiatry. 154:1997;688-690.
13. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844.
14. Fujimoto T., Nakano T., Takano T., Takeuchi K., Yamada K., Fukuzako T., Akimoto H. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol. Psychiatry. 40:1996;14-18.
15. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., Obo Y., Ueyama K., Takigawa M., Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res. 61:1995;193-200.
16. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 122:1999;593-624.
17. Kegeles L.S., Humaran T.J., Mann J.J. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol. Psychiatry. 44:1998;382-398.
18. Sharma R., Venkatasubramanian P.N., Barany M., Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr. Res. 8:1992;43-49.
19. Shen J.F., Saunders J.K. Double inversion recovery improves water suppression in vivo. Magn. Reson. Med. 29:1993;540-542.
20. Shioiri T., Hamakawa H., Kato T., Murashita J., Fujii K., Inubushi T., Takahashi S. Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report. Schizophr. Res. 22:1996;19-26.
21. 1H MR spectra. Magn. Reson. Med. 34:1995;17-24.